A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Inducing Myointimal Hyperplasia Versus Atherosclerosis in Mice: An Introduction of Two Valid Models

11.6K views

⸱

DOI:

10.3791/51459

⸱

May 14th, 2014

* These authors contributed equally

In This Article

Summary

This video shows two models of intimal plaque development in murine arteries and emphasizes the differences in myointimal hyperplasia and atherosclerosis.

Abstract

Various in vivo laboratory rodent models for the induction of artery stenosis have been established to mimic diseases that include arterial plaque formation and stenosis, as observed for example in ischemic heart disease. Two highly reproducible mouse models – both resulting in artery stenosis but each underlying a different pathway of development – are introduced here. The models represent the two most common causes of artery stenosis; namely one mouse model for each myointimal hyperplasia, and atherosclerosis are shown. To induce myointimal hyperplasia, a balloon catheter injury of the abdominal aorta is performed. For the development of atherosclerotic plaque, the ApoE -/- mouse model in combination with western fatty diet is used. Different model-adapted options for the measurement and evaluation of the results are named and described in this manuscript. The introduction and comparison of these two models provides information for scientists to choose the appropriate artery stenosis model in accordance to the scientific question asked.

Introduction

In industrialized nations ischemic heart disease remains a leading cause of mortality1. The causes for coronary artery stenosis are manifold and include myointimal hyperplasia as well as atherosclerosis, with revascularization remaining the most common treatment strategy2. Research models that clearly distinguish between the mechanistic pathways of intimal hyperplasia and atherosclerosis are essential to investigate the pathobiological and pathophysiological processes in arterial plaque development. In this video two different mouse models used to study either the development of myointimal hyperplasia or atherosclerosis are introduced.

Access restricted. Please log in or start a trial to view this content.

Protocol

All animal work should be carried out according to relevant animal care guidelines. Obtain institutional approval for animal work prior to beginning protocol.

1. Myointimal Hyperplasia Model (A)

For the intimal hyperplasia model, purchase C57BL/6J (Stock number 000664, C57BL/6J) mice at the age of 8 weeks weighing approximately 25 g. House mice for these experiments under conventional conditions; feed mice standard mouse chow and provide water ad libitum.

  1. Mouse preparation: Introduce the mouse to an anesthetic state with isoflurane (2%) utilizing an induction chamber. ....

Access restricted. Please log in or start a trial to view this content.

Results

Figure 1 shows different analysis options and the induced disease state for both models. For the intimal hyperplasia model, the analysis of representative cross sections in trichrome staining is shown. From these cross sections, results like I/M ratios, maximum plaque thickness, maximum intimal thickness in the lumen, luminal obliteration in percent, as well as plaque area can be measured and calculated.

To evaluate the outcome of the atherosclerosis model, all methods named a.......

Access restricted. Please log in or start a trial to view this content.

Discussion

Although both diseases result in similar symptoms in the patient, the underlying mechanisms of plaque development and therefore the treatment approaches are very different2. In different forms of arterial stenosis the clinical findings in the patients as well as the timeframe of plaque development depend on the underlying mechanism.

Depending on the clinical findings in the patient, different methods of sample analysis must be performed5,15. It is necessary to adapt the a.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

The authors thank Christiane Pahrmann for technical assistance. S.S. received funding from the Deutsche Forschungsgemeinschaft (DFG) (SCHR992/3-2 and SCHR992/4-2).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Thyoglycollate Broth 3%Fluka70157powder
PFA 4%Electron Microscopy Sciences#157135S20%
Sudan III staining solutionSigma AldrichS4131powder
mouse C57BL/6JJackson LaboratoriesStock # 0006664
mouse ApoE -/-Jackson LaboratoriesStock #002052
Western DietHarlan LaboratoriesTD.88137
hair clipperWAHL8786-451A ARCO SE
ForeneAbbottIsoflurane
microsurgical clampFine Science Tools18055-04Micro-Serrefine - 4 mm
clamp applicatorFine Science Tools18056-14
catheter
10-0 prolene sutureEthicon788G
6-0 prolene sutureEthicon8709H
5-0 prolene sutureEthiconEH7229H
RimadylPfizerCarprofen
Metacam 1.5 mg/mlBoehringer IngelheimMetamizol

References

  1. Manuel, D. G., Leung, M., Nguyen, K., Tanuseputro, P., Johansen, H. Burden of cardiovascular disease in Canada. Can J Cardiol. 19, 997-1004 (2003).
  2. ER, O. B., Ma, X., Simard, T., Pourdjabbar, A., Hibbert, B. Pathogenesis of neointima formation following vascular injury. Cardiova....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

Atherosclerosis ModelBalloon CatheterizationApoE Knockout MiceWestern Diet FeedingAortic Injury SurgeryHistological AnalysisSudan Red StainingComputer MorphometryLuminal Narrowing Measurement